Loading: 100%
HALOZYME THERAPEUTICS INC logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 259 (as per Q3 2016)no data available
Sector Biotechnology, HealthcareBiotechnology, Healthcareno data available
Ticker HALOno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 1705101520
datesClosing price (adj.)
13.10.201717.47
11.10.201717.09
04.10.201717.46
27.09.201717.23
20.09.201716.68
13.09.201713.18
06.09.201712.97
30.08.201712.74
23.08.201712.16
16.08.201711.92
09.08.201712.65
02.08.201712.53
26.07.201713.53
19.07.201713.10
12.07.201713.02
05.07.201713.17
27.06.201713.99
20.06.201714.32
13.06.201713.20
06.06.201712.78
30.05.201712.16
23.05.201712.75
16.05.201714.58
09.05.201713.84
02.05.201714.22
25.04.201713.96
18.04.201712.73
11.04.201712.60
04.04.201713.08
28.03.201714.21
21.03.201713.29
14.03.201713.31
07.03.201712.84
28.02.201712.82
21.02.201712.51
14.02.201712.60
07.02.201712.23
31.01.201711.55
24.01.201711.68
17.01.201710.89
10.01.201712.89
03.01.20179.99
27.12.201610.31
19.12.201611.34
12.12.201611.26
05.12.201611.82
28.11.201611.86
21.11.201612.64
14.11.201613.83
07.11.20168.87
31.10.20168.63
24.10.20169.19
17.10.20169.71
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
17.47n/a
Market Capitalisation
in million USD
2,262n/a
Enterprise Value
in million USD
2,253n/a
Common Shares Outstanding
as per Sep 30, 2016
129,488,000n/a
Preferred Shares Outstanding
as per Sep 30, 2016
n/a
Average Basic Shares Outstanding
TTM
n/a
Average Diluted Shares Outstanding
TTM
125,646,000n/a
Index Membership
n/a
Business Summary
Halozyme Therapeutics Inc is a biotechnology company. It is engaged in research on human enzymes that alter the extracellular matrix and tumor environment.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 221n/a
Receivables 18n/a
Total Current Assets 273n/a
PP&E 4n/a
Total Assets 282n/a
Accounts Payable 5n/a
Current Debt 12n/a
Total Current Liabilities 53n/a
Long-Term Debt 200n/a
Total Liabilities 294n/a
Total Equity -12n/a
Cash Flow
Depreciation & Amortisation 2n/a
Change in Working Capital -17n/a
Operating Cash Flow -50n/a
Net Change in PP&E and Intangibles -4n/a
Investing Cash Flow -113n/a
Dividends Paid 0n/a
Financing Cash Flow 152n/a
Total Change in Cash -10n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value -0.01n/a
Other Ratios
Current Ratio 517.7%n/a
Liabilities to Equity Ratio -2,455.7%n/a
Debt to Assets Ratio 75.1%n/a
Profit & Loss StatementP&L data quality: 76% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Revenue
14
14
56
42
55
75
135
Sales & Services Revenue
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
Cost of revenue
0
-1
0
-1
-6
-23
-29
Cost of Goods & Services
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
Gross Profit
13
13
56
41
49
53
106
Other Operating Income
0
0
0
0
0
0
0
Operating Expenses
-72
-67
-76
-95
-129
-116
-133
Selling, General & Administrative
-15
-15
-18
-25
-32
-36
-40
Selling & Marketing
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
Research & Development
-57
-52
-58
-70
-97
-80
-93
Depreciation & Amortization
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
Operating Income (Loss)
-58
-54
-20
-54
-80
-63
-27
Non-Operating Income (Loss)
0
1
0
0
-3
-6
-5
Interest Expense, net
0
0
0
0
-3
-6
-5
Interest Expense
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
1
0
0
0
0
0
Pretax Income (Loss), Adjusted
-58
-53
-20
-54
-84
-69
-33
Abnormal Gains (Losses)
0
-1
0
0
0
0
0
Acquired In-Process R&D
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
Pretax Income (Loss)
-58
-54
-20
-54
-84
-69
-33
Income Tax (Expense) Benefit, net
0
0
0
0
0
0
0
Current Income Tax
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
-58
-54
-20
-54
-84
-69
-33
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
-58
-54
-20
-54
-84
-69
-33
Minority Interest
0
0
0
0
0
0
0
Net Income
-58
-54
-20
-54
-84
-69
-33
Preferred Dividends
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
-58
-54
-20
-54
-84
-69
-33
Remarks
restated on Mar 12, 2012 n/a
calculated values,
restated on Mar 1, 2013 n/a
calculated values,
restated on Feb 28, 2014 n/a
calculated values,
restated on Mar 2, 2015 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
83
53
100
72
136
108
Cash & Cash Equivalents
n/a
83
53
100
27
61
43
Short Term Investments
n/a
0
0
0
44
74
65
Accounts & Notes Receivable
n/a
2
2
16
9
9
32
Accounts Receivable, Net
n/a
2
2
16
9
9
32
Notes Receivable, Net
n/a
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
Inventories
n/a
0
1
3
6
6
9
Raw Materials
n/a
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
Other Short Term Assets
n/a
4
8
13
8
10
22
Prepaid Expenses
n/a
4
8
13
8
10
22
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
0
0
0
Total Current Assets
n/a
89
64
131
95
161
172
Property, Plant & Equipment, Net
n/a
2
2
4
3
3
4
Property, Plant & Equipment
n/a
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
Other Long Term Assets
n/a
0
0
0
3
2
6
Intangible Assets
n/a
0
0
0
0
0
0
Goodwill
n/a
0
0
0
0
0
0
Other Intangible Assets
n/a
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
0
0
0
3
2
6
Total Noncurrent Assets
n/a
2
2
4
7
5
10
Total Assets
n/a
91
66
135
102
166
182
Liabilities and owners' equity
Payables & Accruals
n/a
12 12425937
13 13172433
10 10055136
18 17504000
17 16964000
31 31291000
Accounts Payable
n/a
4 3820368
8 7556859
2 2271689
3 3135000
3 3003000
4 4499000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
9 8605569
6 5615574
8 7783447
14 14369000
14 13961000
27 26792000
Short Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
22 21862000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
3 2917129
4 4129407
9 8891017
7 7398000
7 7367000
9 9304000
Deferred Revenue
n/a
3 2917129
4 4129407
9 8891017
7 7398000
7 7367000
9 9304000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Total Current Liabilities
n/a
15 15343066
17 17301840
19 18946153
25 24902000
24 24331000
62 62457000
Long Term Debt
n/a
0 0
0 0
31 31111680
50 49772000
50 49860000
28 27971000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
56 55650811
38 37556589
36 35816845
47 47109000
50 50434000
48 48362000
Accrued Liabilities
n/a
0 474389
1 802006
1 861879
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
55 55176422
37 36754583
35 34954966
46 45745000
47 47267000
44 43919000
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
0 0
0 0
0 0
1 1364000
3 3167000
4 4443000
Total Noncurrent Liabilities
n/a
56 55650811
38 37556589
67 66928525
97 96881000
100 100294000
76 76333000
Total Liabilities
n/a
71 70993877
55 54858429
86 85874678
122 121783000
125 124625000
139 138790000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
246 245603251
256 255921762
347 347427367
362 362045000
492 491820000
526 525756000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
-225 -225251795
-245 -245021646
-299 -298573648
-382 -382052000
-450 -450427000
-483 -482658000
Other Equity
n/a
0 0
0 0
0 0
0 17000
0 -41000
0 -99000
Equity Before Minority Interest
n/a
20 20351456
11 10900116
49 48853719
-20 -19990000
41 41352000
43 42999000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
20 20351456
11 10900116
49 48853719
-20 -19990000
41 41352000
43 42999000
Total Liabilities & Equity
n/a
91 91345333
66 65758545
135 134728397
102 101793000
166 165977000
182 181789000
Remarks restated on n/a restated on Mar 12, 2012 n/a restated on Mar 1, 2013 n/a restated on Feb 28, 2014 n/a restated on Mar 2, 2015 n/a restated on Feb 29, 2016 n/a restated on Nov 7, 2016 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Net Income/Starting Line
-58
-53
-20
-54
-83
-68
-32
Net Income
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Depreciation & Amortization
1
2
1
1
1
2
2
Non-Cash Items
5
5
6
8
11
19
23
Stock-Based Compensation
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
Change in Working Capital
12
1
-21
-20
22
0
-29
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
Cash from Operating Activities
-40
-45
-34
-64
-49
-48
-37
Change in Fixed Assets & Intangibles
-1
-1
-1
-1
-2
-1
-2
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
-46
-32
8
Decrease in Long Term Investment
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
0
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
Other Investing Activities
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
Cash from Investing Activities
-1
-1
-1
-1
-48
-33
6
Dividends Paid
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
6
0
0
30
20
0
0
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
39
62
5
83
5
115
13
Increase in Capital Stock
39
62
5
83
5
115
13
Decrease in Capital Stock
0
0
0
0
0
0
0
Other Financing Activities
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
Cash from Financing Activities
45
62
5
113
25
115
13
Net Cash Before Disc. Operations and FX
4
16
-30
47
-72
34
-18
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
Net Cash Before FX
4
16
-30
47
-72
34
-18
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
Net Changes in Cash
4
16
-30
47
-72
34
-18
Remarks
restated on Mar 12, 2012 n/a
calculated values,
restated on Mar 1, 2013 n/a
calculated values,
restated on Feb 28, 2014 n/a
calculated values,
restated on Mar 2, 2015 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo